losartan has been researched along with n-(3-(aminomethyl)benzyl)acetamidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
Akita, Y; Imamura, H; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K | 1 |
Akita, Y; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K | 1 |
3 other study(ies) available for losartan and n-(3-(aminomethyl)benzyl)acetamidine
Article | Year |
---|---|
Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.
Topics: Amidines; Animals; Arginine; Arginine Vasopressin; Benzylamines; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Consciousness; Enzyme Inhibitors; Heart Rate; Hemodynamics; Humans; Indans; Indomethacin; Injections, Intravenous; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Propranolol; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Urotensins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Topics: Aldehydes; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hypertension; Losartan; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tiopronin; Up-Regulation; Ventricular Function, Left | 2008 |
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
Topics: Acetylcysteine; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Cardiomyopathies; Cricetinae; Drug Interactions; Enzyme Inhibitors; Fibrosis; Free Radical Scavengers; Heart; Heart Ventricles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Ventricular Function, Left; Ventricular Remodeling | 2008 |